Short-term survival advantage after plasma exchange in the treatment of acute on chronic liver failure or acute liver failure

References

• Merican I, Guan R, Amarapuka D, et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 2000; 15: 1356–61.
   PubMed Web of Science ®Google Scholar
• Sun CA, Chen HC, Lu SN, et al. Persistent hyperendemicity of hepatitis C virus infection in Taiwan: the important role of iatrogenic risk factors. J Med Virol 2001; 65: 30–4.
   PubMed Web of Science ®Google Scholar
• Sterling RK, Fisher RA. Liver transplantation. Living donor, hepatocyte, and xenotransplantation. Clin Liver Dis 2001; 5: 431–60.
   PubMedGoogle Scholar
• Miwa S, Hashikura Y, Mita A, et al. Living-related liver transplantation for patients with fulminant and subfulminant hepatic failure. Hepatology 1999; 30: 1521–6.
   PubMed Web of Science ®Google Scholar
• O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993; 342: 273–5.
   PubMed Web of Science ®Google Scholar
• Atterbury CE, Maddrey WC, Conn HO. Neomycinsorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial. Am J Dig Dis 1978; 23: 398–406.
   Google Scholar
• Ferenci P, Schafer DF, Kleinberger G, Hoofnagle JH, Jones EA. Serum levels of gamma-aminobutyric-acid-like activity in acute and chronic hepatocellular disease. Lancet 1994; 2: 811–4.
   Google Scholar
• Fischer JE, Baldessarini RJ. False neurotransmitters and hepatic failure. Lancet 1971; 2: 75–80.
   PubMed Web of Science ®Google Scholar
• Freund H, Dienstag J, Lehrich J, et al. Infusion of branched-chain enriched amino acid solution in patients with hepatic encephalopathy. Ann Surg 1982; 196: 209–20.
   PubMed Web of Science ®Google Scholar
• Winikoff S, Glassman MS, Spivak W. Plasmapheresis in a patient with hepatic failure awaiting liver transplantation. I Pediat 1985; 107: 547–9.
   Google Scholar
• Kondrup J, Almdal T, Vilstrup H, Tygstrup N. High volume plasma exchange in fulminant hepatic failure. Int J Artif Organs 1992; 15: 669–76.
   PubMed Web of Science ®Google Scholar
• Ohtake Y, Hirasawa H, Sugai T. Indication of plasmapheresis for patients with severe hepatic dysfunction. Ther Plasmapheresis 1993; 12: 207–10.
   Google Scholar
• Hassanein TI, Wahlstrom HE, Zamora JU, Van Thiel DH. Conventional care of fulminant hepatic failure: medical and surgical aspects. Ther Apheresis 1997; 1: 33–7.
   Google Scholar
• Lepore MJ, McKenna PJ, Martinez DB, Stutman q, Bonanno CA, Conklin EF. Fulminant hepatitis with coma successfully treated by plasmapheresis and hyperimmune Australia-Antibody-rich plasma. Am J Gastroenterol 1972; 58: 381–9.
   PubMed Web of Science ®Google Scholar
• Lepore MJ, Stutman LJ, Bonanno CA, Conklin EF, Robilotti JG Jr, McKenna PJ. Plasmapheresis with plasma exchange in hepatic coma. II. Fulminant viral hepatitis as a systemic disease. Arch Intern Med 1972; 129: 900–7.
   PubMedGoogle Scholar
• Cooper GN, Karlson KE, Clowes GH. Total blood washout and exchange: a valuable tool in acute hepatic coma and Reye's syndrome. Am J Surg 1977; 133: 522–30.
   Google Scholar
• Buckner CD, Clift RA, Volwiler W, Donohue DM, Burnell JM, Saunders FC. Plasma exchange in patients with fulminant hepatic failure. Arch Intern Med 1973; 132: 487–92.
   PubMed Web of Science ®Google Scholar
• Winikoff S, Glassman MS, Spivak W. Plasmapheresis in a patient with hepatic failure awaiting liver transplantation. I Pediat 1985; 107: 547–9.
   Google Scholar
• O'Grady JG, Gimson AE, O'Brien CJ, Pucknell A, Hughes RD, Williams R. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988; 94: 1186–92.
   PubMed Web of Science ®Google Scholar
• Clemmesen JO, Larsen FS, Ejlersen E, Schiodt FV, Ott P, Hansen BA. Haemodynamic changes after high-volume plasmapheresis in patients with chronic and acute liver failure. Eur J Gastroenterol Hepatol 1997; 9: 55–60.
   PubMed Web of Science ®Google Scholar
• Riordan SM, Williams R. Acute liver failure: targeted artificial and hepatocyte-based support of liver regen-eration and reversal of multiorgan failure. J Hepatol 2000; 32(1 Suppl): 63–76.
   PubMedGoogle Scholar
• Watanabe FD, Mullon CJ, Hewitt WR, Arkadopoulos N, Kahaku E, Eguchi S. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann Surg 1997; 225: 484–91.
   PubMed Web of Science ®Google Scholar
• Freeman JG, Matthewson K, Record CO. Plasmapheresis in acute liver failure. Int J Artif Organs 1986; 9: 433–8.
   PubMed Web of Science ®Google Scholar